These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9798025

  • 21. Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
    Nouvet G, Benmessaoud K.
    Drugs; 1995; 49 Suppl 2():423-5. PubMed ID: 8549386
    [No Abstract] [Full Text] [Related]

  • 22. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
    Grassi C, Salvatori E, Rosignoli MT, Dionisio P, Prulifloxacin Study Group.
    Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
    [Abstract] [Full Text] [Related]

  • 23. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 24. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
    Read RC, Kuss A, Berrisoul F, Kearsley N, Torres A, Kubin R.
    Respir Med; 1999 Apr; 93(4):252-61. PubMed ID: 10464889
    [Abstract] [Full Text] [Related]

  • 25. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M, Vinciguerra A, Beghi GF, Paizis G, Giura R, Madonini V, Fiorentini F, Consigli GF, Tonna M, Casalini A.
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [Abstract] [Full Text] [Related]

  • 26. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C, de Wet R, Mandell L, Chang J, Rangaraju M, Nusrat R.
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [Abstract] [Full Text] [Related]

  • 27. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J, Quinn P, Smits P, Sides G.
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [Abstract] [Full Text] [Related]

  • 28. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
    Martinot JB, Carr WD, Cullen S, Heredia Budo JL, Bauer K, MacLeod C, Sanguinetti CM, van Veldhuizen WC, Clarithromycin Once-a-Day Study Group.
    Adv Ther; 2001 Jul; 18(1):1-11. PubMed ID: 11512528
    [Abstract] [Full Text] [Related]

  • 29. Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis.
    Gotfried MH, DeAbate CA, Fogarty C, Mathew CP, Sokol WN.
    Clin Ther; 2001 Jan; 23(1):97-107. PubMed ID: 11219483
    [Abstract] [Full Text] [Related]

  • 30. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
    Langan C, Clecner B, Cazzola CM, Brambilla C, Holmes CY, Staley H.
    Int J Clin Pract; 1998 Jan; 52(5):289-97. PubMed ID: 9796558
    [Abstract] [Full Text] [Related]

  • 31. Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis.
    Adam D.
    Infection; 1993 Jan; 21(4):265-71. PubMed ID: 8225636
    [Abstract] [Full Text] [Related]

  • 32. Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
    Bachand RT.
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():91-100. PubMed ID: 1827107
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 34. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
    McCarty JM, Pierce PF.
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
    [Abstract] [Full Text] [Related]

  • 35. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
    Kemper P, Köhler D.
    Am J Med; 1992 Apr 06; 92(4A):98S-102S. PubMed ID: 1316079
    [Abstract] [Full Text] [Related]

  • 36. Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
    Krumpe PE, Cohn S, Garreltes J, Ramirez J, Coulter H, Haverstock D, Echols R.
    J Antimicrob Chemother; 1999 Mar 06; 43 Suppl A():117-28. PubMed ID: 10225582
    [Abstract] [Full Text] [Related]

  • 37. Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG).
    Khan S, Javaid A, Ghori RA, Mahmood K, Anwer N, Khan SU, Iqbal ZH, Rahman F, Ullah S, Imran K, Akhter N, Khan MK, Siddqui SJ, Fareed A, Khan MH.
    J Pak Med Assoc; 2003 Aug 06; 53(8):338-45. PubMed ID: 14558738
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness of gemifloxacin: results from the GLOBE study.
    Halpern MT, Palmer CS, Zodet M, Kirsch J.
    Am J Health Syst Pharm; 2002 Jul 15; 59(14):1357-65. PubMed ID: 12132563
    [Abstract] [Full Text] [Related]

  • 39. Azithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a single-blind, double-dummy, multicentre study.
    Schouenborg P, Gerdes N, Rasmussen H, Wickers-Nielsen N, Mathiassen E.
    J Int Med Res; 2000 Jul 15; 28(3):101-10. PubMed ID: 10983860
    [Abstract] [Full Text] [Related]

  • 40. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F.
    J Antimicrob Chemother; 1993 Jun 15; 31 Suppl E():153-62. PubMed ID: 8396087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.